Introducing our Early Stage Strategy service
|20th February 2020
Blue Latitude Health introduces our new Early Stage Strategy service, designed to align commercial and medical teams and emphasise the value of the product for the patient, healthcare professional and business from the early phases of drug development.
To learn more about the service - click on the one-pager below and contact mark.assenti@bluelatitude.com
In-progress treatments for COVID-19: an attempt to simplify things
|27th March 2020
Senior Associate Consultant, Manos Mastorakis, takes a look at a number of COVID-19 drugs that are already registered in clinical trials, providing analysis aiming to simplify the current landscape.
Why I became a multiple myeloma patient advocate
|6th March 2020
BLH speaks to MM patient advocate, Peter McCleave, to find out how he has fought to remain positive throughout his treatment journey while simultaneously leading a successful campaign to get more people to sign up to be a blood stem cell donor.
Enhancing the life-cycle of your insight
|28th February 2020
Pharmaceutical and healthcare companies invest a great deal of time and money in commissioning research to address their insight gaps. The process often results in suboptimal return on investment (ROI) due to faulty communication and inefficient documentation of insights. Amit Sheinholtz, Senior Associate User Experience Consultant and Elisa del Galdo, Head of Customer Experience discuss common pitfalls of the negative insight lifecycle and how to avoid them.